Home

Intelligence

Services

Subscriptions

News

About Us

Sign In

 

Document Preview

Acquisition Agreement

 

Click "Add to Cart" button to purchase document. 
Documents are emailed immediately after purchase. 
You can also browse documents by
title, category, or company... or click here for help finding documents.

 

Title:

Acquisition Agreement

Entities:

CardioTech International, Inc.; Colorado MEDtech, Inc.; CMED Catheter and Disposables Technology, Inc.

Date:

2001

Size:

Preview shows 9KB of 125KB total

Price:

$69

ID:

#298191

 

 

► M&A ► Acquisition Agreements
► Biotech & Drugs ► Surgical & Medical Instruments & Apparatus

 

 

Start of Preview


                              ACQUISITION AGREEMENT


This Acquisition Agreement (this "Agreement") dated effective as of
---------
April 30, 2001 is entered into by and among CardioTech International, Inc., a
Massachusetts corporation ("Buyer"), Colorado MEDtech, Inc., a Colorado
------
corporation ("Seller"), and CMED Catheter and Disposables Technology, Inc., a
------
Minnesota corporation and wholly-owned subsidiary of Seller ("Target").
------

WITNESSETH:

WHEREAS, Seller owns Nine hundred fifty five thousand one hundred
sixty two and one-half (955,162.5) shares of Common Stock, par value $0.01 per
share, of Target (the "Shares"), representing all of the issued and outstanding
------
shares of capital stock of Target;

WHEREAS, Seller desires to sell, and Buyer desires to purchase, the
Shares, all upon the terms and conditions provided for herein;

NOW, THEREFORE, in consideration of the recitals above, the mutual
promises set forth herein and other good and valuable consideration, the receipt
and legal sufficiency of which is hereby acknowledged, the parties hereto,
intending to be legally bound hereby, agree as follows:

1. THE ACQUISITION.

1.1 PURCHASE AND SALE. Subject to the terms and conditions of this
Agreement, at the Closing (as hereinafter defined) to be held as provided in
Section 2.1 herein, Seller shall sell the Shares to Buyer, free and clear of all
Encumbrances (as hereinafter defined), and Buyer shall purchase the Shares from
Seller.

1.2 PURCHASE PRICE. The aggregate purchase price for the Shares shall
be One Million Three Hundred Thousand U.S. Dollars (U.S. $1,300,000.00) (the
"Purchase Price"), which shall be paid by Buyer to Seller at the Closing in the
---------------
manner provided in Section 2.3 herein.

2. THE CLOSING.

2.1 PLACE AND TIME. The closing of the sale and purchase of the
Shares (the "Closing") shall take place at the offices of Ellenoff Grossman
--------
Schole & Cyruli, LLP, 370 Lexington Avenue, Suite 1900, New York, New York 10017
at 10:00 a.m. (New York City time) on the date hereof.


{PAGE}
2.2 DELIVERIES BY SELLER. At the Closing, Seller shall deliver to
Buyer, in addition to any other documents, instruments and writings required by
this Agreement to be delivered by Seller at the Closing, the following:

(a) Certificates representing the Shares, duly endorsed for transfer
to Buyer. (Target shall, and Seller shall cause Target to, immediately exchange
those certificates for, and to deliver to Buyer at the Closing, a certificate
representing the Shares in the name of Buyer (without any legend or other
reference to any purported Encumbrance)).

(b) The documents and instruments contemplated by Section 3 herein.

2.3 DELIVERIES BY BUYER.. At the Closing, Buyer shall deliver to
Seller, in addition to any other documents, instruments and writings required by
this Agreement to be delivered by Buyer at the Closing, the following:

(a) A wire transfer of immediately available funds to Seller's
account at Key Bank World Trade, Account name: Colorado MEDtech, Inc. (account
number 769681008934 at 307070267 in an amount equal to Ninety Percent (90%) of
the Purchase Price.

(b) A wire transfer of immediately available funds to the escrow
account of Seller's counsel, Chrisman, Bynum & Johnson, P.C., (Bank One,
Downtown Boulder, Account No. 1069002143 (Trust) ABA/Routing No. 102001017;
phone: (800) 568-8772) in an amount equal to ten percent (10%) of the Purchase
Price to be deposited into the Escrow Fund (as hereinafter defined) and held in
escrow pursuant to the Escrow Agreement (as hereinafter defined) in accordance
with Section 8.4 herein.

(c) The documents and instruments contemplated by Section 4 herein.

2.4 RELEASE. Concurrently with the sale of the Shares to Buyer at the
Closing, Seller shall be deemed, without any further action, to have released
Target from all agreements, commitments, indebtedness, obligations and claims
then existing or which, to the extent arising from or in connection with any
act, omission or state of facts taken or existing on or prior to the Closing
Date (as hereinafter defined), may exist after the Closing Date. Seller (a)
shall execute and deliver to Target at the Closing a release, dated as of the
Closing Date, in substantially the form attached hereto as Exhibit 2.4,
-----------
embodying the terms of this Section 2.4 herein, and (b) shall not assert in any
manner (including, without limitation, by way of defense, offset or counterclaim
(unless in response to a claim by Target) any matter purported to be released by
the preceding sentence.

2.5 EXECUTION AND DELIVERY OF ASSIGNMENT AND ASSUMPTION AGREEMENT.
Target and Seller shall execute and deliver to Buyer an assignment and
assumption agreement covering the Seller's Assumed Liabilities.


2
{PAGE}
3. CONDITIONS TO BUYER'S OBLIGATIONS.

The obligations of Buyer to effect the Closing shall be subject to the
strict satisfaction at or prior to the Closing of the following conditions, any
one or more of which may be waived by Buyer in its sole and absolute discretion:

3.1 NO INJUNCTION.. There shall not be in effect any injunction, order
or decree of a court of competent jurisdiction that prohibits or delays Buyer's
acquisition of the Shares, consummation of any or all of the Contemplated
Transactions (as hereinafter defined), or that will require any divestiture as a
result of Buyer's acquisition of the Shares or that will require all or any part
of the business of the Target to be held separate.

3.2 REPRESENTATIONS, WARRANTIES AND AGREEMENTS. (a) The
representations and warranties of Seller set forth in this Agreement shall be
true and correct in all material respects as of the date of this Agreement and
as of the Closing Date as though made at such time, (b) Seller and Target shall
have performed and complied in all material respects with the agreements
contained in this Agreement required to be performed and complied with by them
prior to or at the Closing, and (c) Buyer shall have received certificates to
the effect set forth in clauses (a) and (b) above signed by the Presidents of
Seller and Target, as applicable.

3.3 COVENANTS AND CONDITIONS. All covenants and conditions
contained in this Agreement or in any exhibit, schedule or ancillary agreement
to be observed by the Seller and/or the Target on or prior to the Closing shall
have been performed or complied with in all material respects.

3.4 LEGAL OPINIONS.. Buyer shall have received an opinion from Peter
J. Jensen, Esq., Seller's and Target's in-house counsel, dated the Closing Date
and in substantially the form of Exhibit 3.4A hereto and an opinion from
-------------
Chrisman Bynum & Johnson, P.C., counsel to Seller, dated the Closing Date in
substantially the form of Exhibit 3.4B hereto.
-----

3.5 LITIGATION.. Except as set forth in Exhibit 3.5, no action or

 

End of Preview

 

Home        Intelligence        Services        Subscriptions        News        About Us

Contact Us       Terms of Use       Resend Documents       Shopping Cart

Copyright © 2008 The Consus Group LLC